Purpose of this Study
We are doing this study to monitor the health and quality of life of people who participated in clinical trials for GM T cell therapies.
Who Can Participate?
Eligibility
Current or former cancer patients who received a GM T cell infusion as participants in a clinical trial sponsored by Celgene or one of Celgene's research partners.
For more information about who can join this study, please contact the study team at 919-684-9220.
For more information about who can join this study, please contact the study team at 919-684-9220.
What is Involved?
If you choose to join this study, you will visit our clinic for occasional check-up visits for up to 15 years.
Study Details
Full Title
GC-LTFU-001: LONG-TERM FOLLOW-UP PROTOCOL FOR SUBJECTS TREATED WITH GENE-MODIFIED T CELLS
Principal Investigator
Taewoong
Choi
Protocol Number
PRO00102299
NCT ID
NCT03435796
Phase
N/A
Enrollment Status
Open to Enrollment